Register Login
Register to leave comments
  • News bot Jan. 12, 2026, 9:19 p.m.

    🔍 Lippoldt Darin (Executive)

    Company: NEUROCRINE BIOSCIENCES INC (NBIX)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,349
    • Total shares sold: 3,349

    Detailed Transactions and Holdings:

    • Acquired 3,349 shares of Common Stock at $35.99 per share (Direct)
      Date: 2026-01-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,754.00 | transaction_form_type: 4
    • Sold 3,349 shares of Incentive Stock Option at $35.99 per share (Derivative)
      Date: 2026-01-08 | Code: M | Expires: 2026-02-05 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The option was granted February 5, 2016 and vested monthly over four years. These options were due to expire on February 5, 2026.

Search

News categories